首页 | 本学科首页   官方微博 | 高级检索  
     


An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis
Authors:R. BOS,C. J. M. VAN LEUVEN,J. STOLK,P. S. HIEMSTRA,H. K. RONDAY,&   W. NIEUWENHUIZEN
Affiliation:TNO-Prevention and Health, Division of Vascular and Connective Tissue Research, Leiden, The Netherlands and Departments of;Pulmonology and;Rheumatology, University Hospital, Leiden, The Netherlands
Abstract:Upon stimulation, polymorphonuclear leucocytes (PMNs) release potent serine proteases, i.e. elastase, cathepsin G and proteinase 3, which contribute to the degradation of tissue and plasma components. Here, we describe the development of a plasma test to assess PMN-mediated fibrinogenolysis as a biochemical marker for actual PMN-derived proteolysis in vivo , useful for monitoring therapeutic efficacy, i.e. of elastase inhibitors. We generated a monoclonal antibody (MAb), designated 1-1/B3, with a high affinity for elastase-degraded fibrinogen (EDF). The epitope for 1-1/B3 becomes exposed in a time-dependent manner during digestion of fibrinogen with purified PMN-derived serine proteases and with isolated PMNs in vitro . However, 1-1/B3 does not react with plasma fibrinogen or with fibrin(ogen) degradation products generated by plasmin or by other active proteases that may occur locally, i.e. metalloproteases and lysosomal cathepsins. On the basis of MAb 1-1/B3, we developed a plasma test for the assessment of PMN-mediated fibrin(ogen) degradation products (PMN-FDP). In a panel of control plasmas, we observed concentrations of PMN-FDP of 8.2 ± 0.9 ng mL−1 ( n  = 18). These values were increased twofold in patients with α1-proteinase inhibitor deficiency (18.6 ± 3.3 ng mL−1; n  = 12;  P  < 0.0001) and even more in patients with sepsis (365.7 ± 97.7 ng mL−1; n  = 16;  P  < 0.0001). Furthermore, synovial tissue extracts from patients with rheumatoid arthritis contained increased levels of PMN-FDP, compared with synovial tissue extracts ( P  < 0.005) from patients with osteoarthritis.
Keywords:Elastase    enzyme immunoassay    fibrinogen    monoclonal antibody    polymorphonuclear leucocytes    pulmonary emphysema    rheumatoid arthritis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号